loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    End Use API: CAS 97-51-8

    Client Email Product
    Menu

    CAS 97-51-8

    Manufacturers/Suppliers

    PharmaCompass

    Bora Pharmaceuticals- Making success more certain.

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Aptra Synthesis (2)

    02 Ocimum Labs (2)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    Product-page Product Main Page
    price-trend Ask Us

    Aptra Synthesis

    Contact Supplier
      Virtual BoothAptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
      Contact Supplier Contact Supplier
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Dronedarone Hydrochloride

      PDF Supplier PDF
      URL Supplier Web Content
      97-51-8
      5-Nitro salicylaldehyde (or) 2-hydr...
      Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and interme...
      Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP standards. We take great pride in producing top-notch intermediates through our fully backward-integrated process. Aptra Synthesis Private Limited (ASPL) stands as one of the rapidly emerging manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and Intermediates.
      Aptra Synthesis

      PharmaLytica 2024

      Not Confirmed

      envelop Contact Supplier

      Aptra Synthesis

      Contact Supplier
        Virtual BoothAptra Synthesis produces APIs, Pellets (Semi-finished Formulations), and Intermediates.
        Contact Supplier Contact Supplier
        Flag India
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Vilazodone

        PDF Supplier PDF
        URL Supplier Web Content
        97-51-8
        5-Nitro salicylaldehyde (or) 2-hydr...
        Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and interme...
        Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP standards. We take great pride in producing top-notch intermediates through our fully backward-integrated process. Aptra Synthesis Private Limited (ASPL) stands as one of the rapidly emerging manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and Intermediates.
        Aptra Synthesis

        PharmaLytica 2024

        Not Confirmed

        envelop Contact Supplier

        Ocimum Labs

        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag India
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Dronedarone Hydrochloride

          PDF Supplier PDF
          URL Supplier Web Content
          97-51-8
          5-Nitrosalicylaldehyde
          Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
          Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Ocimum Labs

          Contact Supplier
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag India
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            Vilazodone

            PDF Supplier PDF
            URL Supplier Web Content
            97-51-8
            5-Nitrosalicylaldehyde
            Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
            Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content
            Post Enquiry
            POST ENQUIRY